Measuring hallmarks of cancer for non-invasive characterization of breast lesions by simultaneous multiparametric 18F-ethylcholine PET- MRI – an exploratory study - Measuring hallmarks of cancer for non-invasive breast cancer diagnosis by 18F-ethylcholine PET-MRI

Medical University of Vienna, Department of Biomedical Imaging and Image-guided Therapy0 个研究点目标入组 100 人开始时间: 2017年10月27日最近更新: 2018年7月23日

试验速览

暂无简介。

•Breast lesion classified as suspicious on conventional imaging (ACR BI-RADS 4 or 5);
•Age > 18 years;
•No previous biopsy in the site of the lesion at the time of PET-MRI;
•Following histopathological confirmation of the lesion by biopsy or surgery.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 70
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 30

•Unstable or non-compliant patients;
•Pregnant or breast-feeding patients;
•Radiation therapy within the last six months or surgical interventions less than 12 weeks
•before PET-MRI examination;
•Known contraindication to the intravenous administration of MR contrast agents or MRI
•examination;
•Known contraindication to the intravenous administration of 18F-methylcholine; • Acute or chronic renal insufficiency;
•Pre- or post-transplant patients.

发起方

Medical University of Vienna, Department of Biomedical Imaging and Image-guided Therapy